The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis

被引:305
作者
Smyth, MJ [1 ]
Krasovskis, E [1 ]
Sutton, VR [1 ]
Johnstone, RW [1 ]
机构
[1] Austin Res Inst, Cellular Cytotox Lab, Heidelberg, Vic 3084, Australia
基金
英国惠康基金;
关键词
D O I
10.1073/pnas.95.12.7024
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multidrug resistance mediated by the drug efflux protein, P-glycoprotein (P-gp), is one mechanism that tumor cells use to escape death induced by chemotherapeutic agents. However, the mechanism by which P-gp confers resistance to a large variety of structurally diverse molecules has remained elusive, In this study, classical multidrug resistant human CEM and K562 tumor cell lines expressing high levels of P-gp were less sensitive to multiple forms of caspase-dependent cell death; including that mediated by cytotoxic drugs and ligation of Fas. The DNA fragmentation and membrane damage inflicted by these stimuli were defined as caspase dependent by various soluble peptide fluoromethyl-ketone caspase inhibitors. Inhibition of P-gp function by the anti-P-gp mAb MRK-16 or verapamil could reverse resistance to these forms of cell death. Inhibition of P-gp function also enhanced drug or Fas-mediated activation of caspase-3 in drug-resistant CEM cells. By contrast, caspase-independent cell death events in the same cells, including those mediated by pore-forming proteins or intact NK cells, were not affected by P-gp expression.:These observations suggest that, in addition to effluxing drugs, P-gp mag play a specific role in regulating some caspase-dependent apoptotic pathways.
引用
收藏
页码:7024 / 7029
页数:6
相关论文
共 49 条
[1]   What have we learnt thus far from mice with disrupted P-glycoprotein genes? [J].
Borst, P ;
Schinkel, AH .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (06) :985-990
[2]   Genetic dissection of the function of mammalian P-glycoproteins [J].
Borst, P ;
Schinkel, AH .
TRENDS IN GENETICS, 1997, 13 (06) :217-222
[3]   ACTIVATION OF THE APOPTOTIC PROTEASE CPP32 BY CYTOTOXIC T-CELL-DERIVED GRANZYME-B [J].
DARMON, AJ ;
NICHOLSON, DW ;
BLEACKLEY, RC .
NATURE, 1995, 377 (6548) :446-448
[4]   AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95) [J].
DHEIN, J ;
WALCZAK, H ;
BAUMLER, C ;
DEBATIN, KM ;
KRAMMER, PH .
NATURE, 1995, 373 (6513) :438-441
[5]  
DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291
[6]   PURIFIED PERFORIN INDUCES TARGET-CELL LYSIS BUT NOT DNA FRAGMENTATION [J].
DUKE, RC ;
PERSECHINI, PM ;
CHANG, S ;
LIU, CC ;
COHEN, JJ ;
YOUNG, JDE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (04) :1451-1456
[7]  
Eguchi Y, 1997, CANCER RES, V57, P1835
[8]   Comparison of apoptosis in wild-type and fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions [J].
Eischen, CM ;
Kottke, TJ ;
Martins, LM ;
Basi, GS ;
Tung, JS ;
Earnshaw, WC ;
Leibson, PJ ;
Kaufmann, SH .
BLOOD, 1997, 90 (03) :935-943
[9]   Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells [J].
Friesen, C ;
Herr, I ;
Krammer, PH ;
Debatin, KM .
NATURE MEDICINE, 1996, 2 (05) :574-577
[10]   HOMOLOGY BETWEEN P-GLYCOPROTEIN AND A BACTERIAL HEMOLYSIN TRANSPORT PROTEIN SUGGESTS A MODEL FOR MULTIDRUG RESISTANCE [J].
GERLACH, JH ;
ENDICOTT, JA ;
JURANKA, PF ;
HENDERSON, G ;
SARANGI, F ;
DEUCHARS, KL ;
LING, V .
NATURE, 1986, 324 (6096) :485-489